- Ethylene glycol used in biological and cryobiological systems is often produced through industrial processes involving ethylene oxide, a highly reactive epoxide widely used as a sterilising gas. Although ethylene oxide is effective for eliminating microbial contaminants, it is also one of the most potent alkylating agents known. When residual ethylene oxide remains dissolved in ethylene glycol, even in trace quantities, it poses a significant threat to cellular systems. This contamination is invisible, chemically reactive, and capable of causing rapid cytotoxicity. More details on ethylene glycol itself can be explored through ethylene glycol.
- Ethylene oxide’s toxicity arises from its strong electrophilic nature. It readily reacts with nucleophilic groups in biological molecules, including amino groups in proteins, thiol groups in enzymes, and nucleic acids. These reactions lead to protein denaturation, enzyme inactivation, DNA alkylation, and membrane disruption. In biological systems, such damage manifests as immediate loss of cell viability, impaired metabolic activity, and structural breakdown. When ethylene glycol contaminated with ethylene oxide is used as a cryoprotective agent, the toxic epoxide overwhelms the protective function of the glycol, resulting in cell death during exposure, cooling, or thawing.
- The presence of ethylene oxide residues also interferes with biochemical assays, tissue preservation, and reproductive biology applications. In cell culture, contaminated ethylene glycol causes membrane leakage, oxidative stress, and apoptosis. In embryo or oocyte handling, even minute amounts of ethylene oxide can compromise developmental potential. In protein or enzyme formulations, ethylene oxide modifies functional groups, reducing activity and altering structural stability. These effects make ethylene oxide contamination one of the most critical purity concerns when ethylene glycol is used in any biological context.
- Ethylene oxide contamination is particularly problematic because it is not removed by simple filtration or dilution. Ethylene oxide dissolves readily in ethylene glycol and remains chemically active unless deliberately decomposed. Commercial suppliers may sterilise ethylene glycol using ethylene oxide gas, and without adequate degassing or decomposition steps, the final product retains harmful residues. Laboratories using ethylene glycol for cryopreservation, vitrification, or biochemical preparations must therefore ensure that the glycol is free of ethylene oxide before use.
- A reliable method for removing ethylene oxide residues is to incubate the ethylene glycol at 37 °C for 48 hours. At this temperature, ethylene oxide undergoes slow hydrolysis and decomposition into less reactive derivatives, while ethylene glycol itself remains chemically stable. This controlled incubation neutralises the toxic epoxide and restores the glycol’s suitability for biological applications. After this treatment, ethylene glycol can be safely used in cryopreservation, cell culture, and biochemical systems without risk of ethylene oxide‑induced cytotoxicity.
